Ankylosing Spondylitis Disease Activity Score (ASDAS) by anti-drug
Por um escritor misterioso
Descrição
Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
Achieving Ankylosing Spondylitis Remission and Next Steps
The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry - Jinhyun Kim, Min Jung Kim, Geun Young Oh, Sun Kyung Lee
A) Ankylosing Spondylitis Disease Activity Score (ASDAS) clinically
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe - The Lancet Regional Health – Europe
Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis – topic of research paper in Clinical medicine.
WO2021067465A1 - Treating spondyloarthritic and psoriatic conditions with upadacitinib - Google Patents
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
Disease activity state by ASDAS-CRP vs. ASDAS-qCRP (A) and ASDAS-CRP
Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE) – topic of research
Disease Control Data, Ankylosing Spondylitis
de
por adulto (o preço varia de acordo com o tamanho do grupo)